Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association

Therapie. 2006 Nov-Dec;61(6):531-3. doi: 10.2515/therapie:2006075.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antimanic Agents / adverse effects
  • Antimanic Agents / therapeutic use*
  • Bipolar Disorder / chemically induced*
  • Bipolar Disorder / complications
  • Bipolar Disorder / drug therapy
  • Bipolar Disorder / psychology*
  • Cyclohexanols / adverse effects*
  • Cyclohexanols / therapeutic use
  • Depressive Disorder / psychology
  • Drug Combinations
  • Humans
  • Male
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Serotonin Syndrome / psychology*
  • Valproic Acid / adverse effects
  • Valproic Acid / therapeutic use*
  • Venlafaxine Hydrochloride

Substances

  • Antimanic Agents
  • Cyclohexanols
  • Drug Combinations
  • Serotonin Uptake Inhibitors
  • Valproic Acid
  • Venlafaxine Hydrochloride